Fwd: On Your Authority, I'll Push This Through...

---------- Forwarded message ----------
From: Wall Street Daily <wallstreetdaily@wallstreetdaily.com>
Date: Sat, Aug 30, 2014 at 6:32 AM
Subject: On Your Authority, I'll Push This Through...
To: IAMMEJTM@gmail.com

You are receiving this e-mail as a part of your free subscription to the Wall Street Daily e-letter. Click here to manage your subscription.

Dear Wall Street Daily Nation, I have two evolving flashpoints to report about our resident income genius, Lee Lowell... First, the offer to secure Lee's latest "cash codes" expires tomorrow at midnight. Second, he just hit a major milestone. A milestone that may ultimately put him into the record books as the proprietor of the greatest income strategy in history. You see, he recently released his 120th cash-paying code. Lee began issuing these codes in late 2008. Since then, all 120 of them (100% of them) have paid out cash. The typical code pays out around $1,050. Those who've been around since the beginning have now had an opportunity to collect upwards of $92,190 in cash. With such historical precedence, I can say the following with 100% confidence... If you punch his latest codes into your computer, and execute the other simple basics of Lee's strategy just as he suggests in his email alerts... You'll have $1,050 in your account by this time on Tuesday, at which point you can call your broker and ask him to wire you the funds. It's money you never have to give back, either. To get the details on today's codes, click here. Act quickly though, the offer to secure Lee's latest codes expires tomorrow at midnight. Good investing, Justin Fritz Editor-in-Chief, Wall Street Daily You are receiving this e-mail at as a part of your free subscription to the Wall Street Daily e-letter. Manage your subscription. Or to cancel by mail or for any other subscription issues, write us at: Wall Street Daily Attn: Member Services 105 West Monument Street Baltimore, MD 21201 Copyright 2014 Wall Street Daily, LLC All Rights Reserved Wall Street Daily, LLC. 105 West Monument Street Baltimore, MD 21201 North America: 1.855.405.3939; Fax: 1 410.246.2297 International: +443.353.4052; Fax: +1 410.246.2297 Website | Contact Us The mailbox associated with this email address is not monitored, so please do not reply. Your feedback is very important to us, so if you would like to contact us with a question or comment, please click here: http://wallstreetdaily.com/customer-feedback Wall Street Daily, LLC is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that investment markets have inherent risks and our past performance does not assure the same future results. The stated returns may also include option trades. Protected by copyright laws of the United States and international treaties. This newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Wall Street Daily, LLC. 105 W. Monument Street, Baltimore MD 21201.

--
Jeremy Tobias Matthews

Fwd: CDC Influenza News and Highlights

---------- Forwarded message ----------
From: Centers for Disease Control & Prevention <cdc@service.govdelivery.com>
Date: Fri, Aug 29, 2014 at 11:27 AM
Subject: CDC Influenza News and Highlights
To: iammejtm@gmail.com

Having trouble viewing this email? View it as a Web page. View the Latest Flu information From This Week. Influenza (Flu) Saving Lives. Protecting People. TM www.cdc.gov CDC Influenza News and Highlights August 29, 2014   What's New? Flu Prevention Partners Flu Season Events: Submit Your Plans NIVDP Influential News, August 2014 Are You Ready for Flu? (Webinar) Quadrivalent Flu Vaccine Questions and Answers Weekly Influenza Surveillance CDC has published the 2014-2015 recommendations for the prevention and control of influenza. CDC recommends an annual flu vaccine for everyone 6 months of age and older. Flu activity is low across the United States now, but usually begins to increase in October and most commonly peaks between January and March. Make plans to get your flu vaccine this fall. Learn More! What You Should Know for the 2014-2015 Season Key Facts About Seasonal Flu 2014-2015 Flu Season Symptoms & Severity People at High Risk from Flu 2014-15 Provider Information: Influenza VISs Now Available Live, Intranasal Influenza VIS for Patients Inactivated Influenza VIS for Patients Content source: National Center for Immunization and Respiratory Diseases Modify/Update Subscriber Preferences  |  Unsubscribe  |  Send Feedback  |  Learn about CDC Updates Questions or problems? Please contact support@govdelivery.com.       This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: Centers for Disease Control and Prevention · 1600 Clifton Rd · Atlanta, GA 30333 · 1-800-CDC-INFO (800-232-4636)

--
Jeremy Tobias Matthews

Fwd: SEC New York Stock Exchange Update

---------- Forwarded message ----------
From: Securities and Exchange Commission <sec@service.govdelivery.com>
Date: Fri, Aug 29, 2014 at 11:05 AM
Subject: SEC New York Stock Exchange Update
To: iammejtm@gmail.com

You are subscribed to receive information alerts about the New York Stock Exchange from the Securities and Exchange Commission.

This information has recently been updated and is now available.

http://sec.gov/rules/sro/nyse.shtml

 

 

You can update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. For more information on collecting personally identifiable information, please read the SEC's privacy policy. Manage Preferences | Delete Profile | Help

This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: Securities and Exchange Commission · 100 F Street, NE · Washington, DC 20549 · 202-551-4120

--
Jeremy Tobias Matthews

Fwd: U.S. Department of the Treasury Daily Treasury Long-Term Rates Update

---------- Forwarded message ----------
From: U.S. Department of the Treasury <subscriptions@subscriptions.treas.gov>
Date: Fri, Aug 29, 2014 at 3:04 PM
Subject: U.S. Department of the Treasury Daily Treasury Long-Term Rates Update
To: iammejtm@gmail.com

You are subscribed to Daily Treasury Long-Term Rates for U.S. Department of the Treasury. This information has recently been updated, and is now available. Questions? Contact Us   STAY CONNECTED:   SUBSCRIBER SERVICES: Manage Preferences  |  Unsubscribe  |  Help This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: U.S. Department of the Treasury · 1500 Pennsylvania Ave NW · Washington, DC 20220 · 202-622-2000

--
Jeremy Tobias Matthews

Fwd: CDER New August 28. 2014

---------- Forwarded message ----------
From: U.S. Food & Drug Administration (FDA) <fda@service.govdelivery.com>
Date: Thu, Aug 28, 2014 at 7:10 AM
Subject: CDER New August 28. 2014
To: iammejtm@gmail.com

What's New on the FDA Drugs Site

August 27, 2014

• FDA Drug Shortages: New and Updated
  • Bupivacaine Hydrochloride (Marcaine, Sensorcaine) Injection (Currently in Shortage)
  • Calcium Gluconate Injection (Currently in Shortage)
  • Cefazolin Injection (Currently in Shortage)
  • Cefotetan Disodium Injection (Currently in Shortage)
  • Dexamethasone Sodium Phosphate Injection (Currently in Shortage)
  • Dihydroergotamine Mesylate Injection (Currently in Shortage)
  • Famotidine Injection (Currently in Shortage)
  • Haloperidol Lactate Injection (Currently in Shortage)
  • Heparin Sodium Injection (Currently in Shortage)
  • Lidocaine Hydrochloride (Xylocaine) Injection (Currently in Shortage)
  • Magnesium Sulfate Injection (Currently in Shortage)
  • Ondansetron (Zofran) Injection (Currently in Shortage)
  • Phosphate (Glycophos) Injection (Currently in Shortage)
  • Potassium Chloride Injection (Currently in Shortage)
  • Sodium Chloride 0.9% Injection Bags (Currently in Shortage)
  • Sodium Chloride 23.4% Injection (Currently in Shortage)
  • Tobramycin Solution for Injection (Currently in Shortage)
• Drugs@FDA Data Files (updated)
• Pediatric List of Determinations including Written Request (updated)

---

New and Generic Drug Approvals

August 26, 2014

Drug Name	Active Ingredient	Dosage Form/Route	Sponsor	Submission Type
Dostinex	cabergoline	Tablet;Oral	Pharmacia and Upjohn	Labeling Revision
Entecavir	entecavir	Tablet;Oral	Teva Pharms Usa	Approval
Furosemide	furosemide	Injectable;Injection	Emcure Pharms Ltd	Approval
Memantine Hydrochloride	memantine hydrochloride	Tablet;Oral	Macleods Pharms Ltd	Tentative Approval
Nevirapine	nevirapine	Tablet, Extended Release;Oral	Mylan Labs Ltd	Tentative Approval
Primaxin	cilastatin sodium; imipenem	Injectable;Injection	Merck	Manufacturing Change or Addition
Promacta	eltrombopag olamine	Tablet;Oral	Glaxosmithkline	Efficacy Supplement with Clinical Data to Support
Telmisartan	telmisartan	Tablet;Oral	Zydus Pharms Usa Inc	Approval
Telmisartan and Amlodipine	telmisartan;amlodipine	Tablet;Oral	Mylan Pharms Inc	Approval
Xalkori	crizotinib	Capsule;Oral	Pf Prism Cv	Manufacturing Change or Addition

 

---

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

---

This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420

--
Jeremy Tobias Matthews

Fwd: NIH to Launch Human Safety Study of Ebola Vaccine Candidate

---------- Forwarded message ----------
From: National Institutes of Health (NIH) <nih.ocpl@service.govdelivery.com>
Date: Thu, Aug 28, 2014 at 7:17 AM
Subject: NIH to Launch Human Safety Study of Ebola Vaccine Candidate
To: iammejtm@gmail.com

Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).   NIH to Launch Human Safety Study of Ebola Vaccine Candidate 08/28/2014 09:30 AM EDT Trial is First in Series of Accelerated Safety Studies of Ebola Vaccines. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact NIHinfo@od.nih.gov. Before writing, please view our Frequently Asked Questions page, our A-Z Health Topics page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®  This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612

--
Jeremy Tobias Matthews